Multimorbidity
Multimorbidity is the co-occurrence of two or more chronic medical conditions in an individual. It is a common condition, especially among the elderly population, and it poses significant challenges to healthcare systems worldwide.
Definition[edit]
Multimorbidity is defined as the presence of two or more chronic medical conditions in a single individual. These conditions can include both physical and mental health disorders. The concept of multimorbidity is distinct from comorbidity, which refers to the presence of additional conditions in a patient with a particular index disease.
Epidemiology[edit]
The prevalence of multimorbidity varies widely depending on the population studied and the definitions used. However, it is generally agreed that multimorbidity is common, especially among the elderly population. In high-income countries, more than half of adults aged 65 and older have two or more chronic conditions.
Impact[edit]
Multimorbidity has significant implications for individuals and healthcare systems. It is associated with reduced quality of life, increased healthcare utilization, and higher healthcare costs. Moreover, managing multimorbidity is complex due to the need for multiple medications and the potential for drug interactions.
Management[edit]
The management of multimorbidity requires a patient-centered approach that takes into account the individual's preferences, needs, and values. This often involves a multidisciplinary team of healthcare professionals, including doctors, nurses, pharmacists, and social workers.
Research[edit]
Research on multimorbidity is a growing field. Current areas of focus include understanding the patterns of multimorbidity, identifying risk factors, and developing effective interventions.
See also[edit]
Multimorbidity[edit]
-
Multimorbidity
-
Multimorbidity
-
Multimorbidity
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
